Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
18/04/2026
Trump boasts about falling oil prices.
Latest
4 m ago
Mindray Medical: The profit margin for 2026 is expected to decrease slightly, but the rate of decrease will significantly narrow.
8 m ago
What to do after the coal power plant is retired? Former chairman of State Power Investment Corporation, Wang Binghua: It is feasible to convert to a nuclear energy project.
8 m ago
In March, the monthly active users of securities App increased by 3.6% compared to the previous month.
9 m ago
Every AI Express, China Post Securities released a research report on April 17th giving Wumei Biotechnology (603983.SH) a "hold" rating. The main reasons for the rating include: 1) Income split: single product and double brand driving, significant differentiation in channel structure; 2) Profit split: increased advertising + depreciation of large buildings, squeezing short-term profit space; 3) Company outlook: channel optimization + dual brand operation, jointly driving the company's future development. (Daily Economic News)
9 m ago
Faraday Future announced that it has received 45 million dollars in new financing; it plans to hold its annual shareholder meeting on May 22 to seek approval for several key proposals aimed at accelerating the implementation of its EAI strategy and safeguarding shareholder interests.
See all latest